An analysis of final 2021 DAWN data presents: (1) nationally representative weighted estimates, including percent and unadjusted rates per 100,000, for all drug-related emergency department (ED) visits, (2) nationally representative weighted estimates for the top five drugs in drug-related ED visits, (3) the assessment of monthly trends and drugs involved in polysubstance ED visits in a subset of sentinel hospitals, and (4) the identification of drugs new to DAWN’s Drug Reference Vocabulary (SAMHSA)
Archives for December 2022
Bibliography: All Publications
Joint Committee on Justice has published its Report on an examination of the present approach to sanctions for possession of certain amounts of drugs for personal use
The Joint Committee on Justice has published its Report on an examination of the present approach to sanctions for possession of certain amounts of drugs for personal use in which it makes a series of recommendations on the issue (Houses of the Oireachtas, Ireland)
Deaths in prison
Examining causes, responses, and prevention of deaths in prison worldwide (Penal Reform International)
Quantitative and qualitative assessments of data quality within the European Web Survey on Drugs
This paper assesses data quality in the first two rounds of the European Web Survey on Drugs (EMCDDA)
Cannabis in Australia
More than a third of Australians aged over 14 have used cannabis at least once – 37%, or 7.6 million people. Around 2.4 million Australians used cannabis in 2019, as did 200 million people worldwide (Penington Institute)
Harm Reduction for People Who Use Drugs
Priorities for Investment and Increased Impact in HIV Programming (The Global Fund)
National naloxone programme Scotland – Quarterly monitoring bulletin
Quarterly Monitoring Bulletin April to June (Q1) 2022/23 (Public Health Scotland)
Evidence and practice briefing: Best practice in pre-court disposals for possession of drugs
Data from the Office for National Statistics shows that since 2012/13 there has been a rising trend in drug use amongst adults in England and Wales (Centre for Justice Innovation)
Members of the European Parliament endorse a broader mandate for the EMCDDA
Members of the European Parliament (MEPs) from the Civil Liberties Committee (LIBE) adopted a report creating the European Union Drugs Agency and endowing it with new competences (EMCDDA)
Drug and alcohol services – co-occurring substance use and mental health concerns: literature and evidence review
This report provides a rapid review of the literature on co-occurring substance use and mental health concerns and the integration of mental health and substance use services in Scotland (Scottish Government)
HIV Action Plan monitoring and evaluation framework
The 2021 data has shown positive signs of recovery, but that recovery is uneven. The number of all people with diagnosed HIV infection and in care who were treated and virally suppressed remained extremely high between 2019 and 2021 (UK Government)
Trends in the availability and types of drugs sold on the internet via cryptomarkets, October 2021 – September 2022
This bulletin series reports on trends in the availability and types of drugs sold on the internet via cryptomarkets over a 12-month period (a new bulletin is released typically every four months). The current bulletin focuses on analysis of drug listings on cryptomarkets from 1 October 2021 to 30 September 2022 (NDARC)
